SC: Confirmation of an Auction Sale Does Not Bar Judicial Scrutiny of Reserve Price Valuation || Supreme Court Sets Aside Conviction of Four Men in a 1998 Gang Rape Case || Supreme Court: Privy Purse Privileges of Princely Rulers are Not Enforceable Legal Rights || Delhi HC: Repeated Court Summons May Distress and Re-Traumatize Child Sexual Assault Victims || Jammu and Kashmir High Court: Labeling Someone as a Terrorist Associate Amounts to Defamation || Delhi HC: Setting Aside or Altering a Judge’s Order by a Higher Court Doesn’t Affect Their Integrity || Delhi High Court: Accused Cannot be Faulted For Smart Replies; Interrogator Must be Sharper || Supreme Court: Belated Jurisdictional Challenge Impermissible After Participation in Arbitration || Supreme Court: Failure to Prove Specific Overt Acts of Each Unlawful Assembly Member Not Fatal || Supreme Court: Parental Salary Alone Cannot Determine OBC Creamy Layer Status

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :